Genetic loci and metabolic states associated with murine epigenetic aging

  1. Khyobeni Mozhui  Is a corresponding author
  2. Ake T Lu
  3. Caesar Z Li
  4. Amin Haghani
  5. Jose Vladimir Sandoval-Sierra
  6. Yibo Wu
  7. Robert W Williams
  8. Steve Horvath
  1. University of Tennessee Health Science Center, United States
  2. University of California, Los Angeles, United States
  3. University of California Los Angeles David Geffen School of Medicine, United States
  4. University of Geneva, Switzerland

Abstract

Changes in DNA methylation (DNAm) are linked to aging. Here, we profile highly conserved CpGs in 339 predominantly female mice belonging to the BXD family for which we have deep longevity and genomic data. We use a 'pan-mammalian' microarray that provides a common platform for assaying the methylome across mammalian clades. We computed epigenetic clocks and tested associations with DNAm entropy, diet, weight, metabolic traits, and genetic variation. We describe the multifactorial variance of methylation at these CpGs, and show that high fat diet augments the age-associated changes. Entropy increases with age. The progression to disorder, particularly at CpGs that gain methylation over time, was predictive of genotype-dependent life expectancy. The longer-lived BXD strains had comparatively lower entropy at a given age. We identified two genetic loci that modulate rates of epigenetic age acceleration (EAA): one on chromosome (Chr) 11 that encompasses the Erbb2/Her2 oncogenic region, and a second on Chr19 that contains a cytochrome P450 cluster. Both loci harbor genes associated with EAA in humans including STXBP4, NKX2-3, and CUTC. Transcriptome and proteome analyses revealed associations with oxidation-reduction, metabolic, and immune response pathways. Our results highlight concordant loci for EAA in humans and mice, and demonstrate a tight coupling between the metabolic state and epigenetic aging.

Data availability

The normalized microarray data and raw files are available from the NCBI Gene Expression Omnibus (accession ID GSE199979). The HorvathMammalMethylChip40 array manifest files and genome annotations of CpGs can be found on Github at https://github.com/shorvath/MammalianMethylationConsortium.79 Individual level BXD data, including the processed microarray data are available on www.genenetwork.org on FAIR+ compliant format; data identifiers, and way to retrieve data are described in Supplementary file 13.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Khyobeni Mozhui

    Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, United States
    For correspondence
    kmozhui@uthsc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6623-4112
  2. Ake T Lu

    Department of Human Genetics, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    No competing interests declared.
  3. Caesar Z Li

    Department of Human Genetics, University of California Los Angeles David Geffen School of Medicine, Los Angeles, United States
    Competing interests
    No competing interests declared.
  4. Amin Haghani

    Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6052-8793
  5. Jose Vladimir Sandoval-Sierra

    Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2007-6582
  6. Yibo Wu

    University of Geneva, Geneva, Switzerland
    Competing interests
    No competing interests declared.
  7. Robert W Williams

    Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, United States
    Competing interests
    No competing interests declared.
  8. Steve Horvath

    Department of Human Genetics, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    Steve Horvath, is a founder of the non-profit Epigenetic Clock Development Foundation, which plans to license several of his patents from his employer, University of California Regents. The Regents of the University of California filed a patent application (publication number WO2020150705) related to the HorvathMammalMethylChip40 and clock computation for which he is named an inventor..

Funding

National Institute on Aging (R21AG055841)

  • Khyobeni Mozhui

National Institute on Aging (R01AG043930)

  • Robert W Williams

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were in accordance to protocol approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Tennessee Health Science Center. Protocol numbers 12-148.0 (2012-2015), 15-124.0 (2015-2018), and 18-094.0 (2018-present).

Copyright

© 2022, Mozhui et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,137
    views
  • 298
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Khyobeni Mozhui
  2. Ake T Lu
  3. Caesar Z Li
  4. Amin Haghani
  5. Jose Vladimir Sandoval-Sierra
  6. Yibo Wu
  7. Robert W Williams
  8. Steve Horvath
(2022)
Genetic loci and metabolic states associated with murine epigenetic aging
eLife 11:e75244.
https://doi.org/10.7554/eLife.75244

Share this article

https://doi.org/10.7554/eLife.75244

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ananda Kishore Mukherjee, Subhajit Dutta ... Shantanu Chowdhury
    Research Article

    Telomeres are crucial for cancer progression. Immune signalling in the tumour microenvironment has been shown to be very important in cancer prognosis. However, the mechanisms by which telomeres might affect tumour immune response remain poorly understood. Here, we observed that interleukin-1 signalling is telomere-length dependent in cancer cells. Mechanistically, non-telomeric TRF2 (telomeric repeat binding factor 2) binding at the IL-1-receptor type-1 (IL1R1) promoter was found to be affected by telomere length. Enhanced TRF2 binding at the IL1R1 promoter in cells with short telomeres directly recruited the histone-acetyl-transferase (HAT) p300, and consequent H3K27 acetylation activated IL1R1. This altered NF-kappa B signalling and affected downstream cytokines like IL6, IL8, and TNF. Further, IL1R1 expression was telomere-sensitive in triple-negative breast cancer (TNBC) clinical samples. Infiltration of tumour-associated macrophages (TAM) was also sensitive to the length of tumour cell telomeres and highly correlated with IL1R1 expression. The use of both IL1 Receptor antagonist (IL1RA) and IL1R1 targeting ligands could abrogate M2 macrophage infiltration in TNBC tumour organoids. In summary, using TNBC cancer tissue (>90 patients), tumour-derived organoids, cancer cells, and xenograft tumours with either long or short telomeres, we uncovered a heretofore undeciphered function of telomeres in modulating IL1 signalling and tumour immunity.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.